Metabolomics Recursos do setor
Portfólio de instrumento
Pegasus GC-HRT
GC-TOFMS de alta resolução
Pegasus GC-HRT 4D
GCxGC-TOFMS de alta resolução
Pegasus BT 4D
Espectrômetro de massa por tempo de voo com GCxGC
Notas de aplicação
Saiba mais sobre nossas soluções para Metabolomics com nossa biblioteca de notas de aplicação relacionadas.
Notícias ou histórias
1 novembro 2021
Metabolomics and GCxGC are Changing How We Monitor Our Health
Learn how Jane Hill is using GCxGC and the study of metabolomics to develop a new method of diagnosing lung infections.
19 março 2020
Medical Investigation using Breath Analysis and GCxGC-TOFMS: Optimizing Data for Accurate Treatment
Using GC-GC-TOFMS, Jef Focant is able to diagnose the asthma phenotype in patients.
Vídeos e webinars
- 1Breath Analysis – Investigating the Human Volatome De 7 fevereiro 2022
- 2Science from Beyond the Grave: a Virtual GC Symposium De 31 outubro 2021
- 3Dramatically Increase Information Content in Metabolomics Studies De 24 outubro 2013
- 4High Resolution GCMS Applications in Metabolomics De 21 fevereiro 2013
- 5Small Molecule Metabolite Profiling and Characterization De 16 junho 2011
- 6Mold Metabolites De 17 fevereiro 2011
Cartazes e apresentações
- Fisher ratio analysis for metabolite discovery in Pacu fish Tile-based Fisher ratio (F-ratio) analysis is used to discover and quantify metabolites in Argentinian pacu fish, using data collected by comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry (GCxGC-TOFMS) via a LECO Pegasus BT 4D instrument.
- Breath Volatile Compounds in Asthma Patients Jean-Francois Focant from the University of Liege (Belgium) discusses utilizing two-dimensional gas chromatography to study volatile compounds in breath samples of asthma patients.
- The Discovery of Potential Cancer Biomarkers in Human Plasma using GC- and GCxGC-TOFMS
- Metabolite Profiling Type-2 Diabetes Patient Plasma
- Steroid Method Development GCxGC-HRT+
- Disease Biomarker Identification via GC-MS Rodent liver samples were analyzed via GC-MS for Non-Alcoholic Fatty Liver Disease (NAFLD) biomarkers.